You have 9 free searches left this month | for more free features.

Tumour Treating Fields

Showing 26 - 50 of 2,511

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prospective Tissue Collection Research Protocol

Recruiting
  • Solid Tumor
  • Tumour tissue collection
  • New York, New York
  • +17 more
Jan 16, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Malignant Tumor in the Leptomeninges Trial in

Not yet recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Digital Photography
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Feb 28, 2023

Pain, Joint, Complex Regional Pain Syndromes, Ankle Disease Trial in Bari (PEMFS)

Not yet recruiting
  • Pain, Joint
  • +3 more
  • PEMFS
  • Bari, Italy
    Angela Notarnicola
Jun 19, 2023

Breast Cancer, Sentinel Lymph Node Trial in Zhubei (Near infrared fluorescence navigated sentinel lymph node mapping)

Recruiting
  • Breast Cancer
  • Sentinel Lymph Node
  • Near infrared fluorescence navigated sentinel lymph node mapping
  • Zhubei, HsinChu County, Taiwan
    National Taiwan University Hospital Hsin-Chu Branch Biomedical P
May 6, 2022

Clear Cell Renal Cell Carcinoma Metastatic, TNBC - Triple-Negative Breast Cancer, Head Neck Cancer Trial (CA9hu-1)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma Metastatic
  • +4 more
  • (no location specified)
Jan 13, 2023

Glioma Trial in Atlanta (Optune device)

Recruiting
  • Glioma
  • Optune device
  • Atlanta, Georgia
  • +2 more
May 12, 2022

Lung Cancer, Esophageal Cancer, Mesothelioma; Lung Trial (LCR Meter (Brand: Keysight, Serial Number:E498AL))

Not yet recruiting
  • Lung Cancer
  • +2 more
  • LCR Meter (Brand: Keysight, Serial Number:E498AL)
  • (no location specified)
Mar 15, 2021

Contrast Enhanced Breast CT for Diagnosis and Staging of Breast

Not yet recruiting
  • Breast Cancer
  • Dedicated breast CT
  • (no location specified)
May 30, 2022

Gadolinium-based Contrast Agent Reduction in Brain MRI (MAGNET)

Recruiting
  • Brain Diseases
  • Low-dose GBCA levels
  • Beijing, Beijing, China
    Beijing Tiantan Hospital
Mar 2, 2023

Lung Cancer, Primary Tumor, Metastases Trial in Tønsberg (Genome analysis of tissue samples.)

Active, not recruiting
  • Lung Cancer
  • +2 more
  • Genome analysis of tissue samples.
  • Tønsberg, Norway
    Vestfold Hospital Trust
Jan 19, 2023

Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw

Recruiting
  • Advanced Ovarian Carcinoma
  • +7 more
  • Bydgoszcz, Kujawsko-pomorskie, Poland
  • +2 more
Mar 7, 2023

Hepatocellular Carcinoma Trial in Winston-Salem (TheraBionic, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Oct 26, 2022

Hepatocellular Carcinoma Trial in Singapore (Surgical Resection, Adjuvant Atezolizumab-Bevacizumab Therapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Surgical Resection
  • Adjuvant Atezolizumab-Bevacizumab Therapy
  • Singapore, Singapore
  • +5 more
Aug 23, 2022

Wilms Tumor, Renal Cancer Trial in Birmingham (Indocyanine Green (ICG))

Not yet recruiting
  • Wilms Tumor
  • Renal Cancer
  • Indocyanine Green (ICG)
  • Birmingham, United Kingdom
    Birmingham children's hospital
Feb 9, 2023

Chronic Wounds Trial (Pulsed ElectroMagnetic Field (PEMF) therapy, Pulsed ElectroMagnetic (PEMF) therapy)

Not yet recruiting
  • Chronic Wounds
  • Pulsed ElectroMagnetic Field (PEMF) therapy
  • Pulsed ElectroMagnetic (PEMF) therapy
  • (no location specified)
Aug 6, 2022

Bladder Cancer Trial in Hong Kong (Bipolar transurethral standard resection, Bipolar transurethral en bloc resection)

Completed
  • Bladder Cancer
  • Bipolar transurethral standard resection
  • Bipolar transurethral en bloc resection
  • Hong Kong, Hong Kong
  • +12 more
Jun 24, 2022

Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • carboplatin chemotherapy
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Nov 3, 2023

Moderate Depression, Severe Depressive Episode Without Psychotic Symptoms, Recurrent Depressive Disorder, Current Episode

Recruiting
  • Moderate Depression
  • +3 more
  • Transcranial Pulsed Electromagnetic Fields (T-PEMF) delivered via a headband
  • No treatment delivered via headband
  • Frederiksberg, Capital Region, Denmark
    Psychiatric Center Copenhagen
Aug 15, 2023

Adnexal Mass, Adnexal Tumor, Adnexal Cyst Trial in Leuven (Ultrasound)

Recruiting
  • Adnexal Mass
  • +3 more
  • Ultrasound
  • Leuven, Vlaams-Brabant, Belgium
    UZ Leuven
Jul 25, 2023

B-cell Non-Hodgkin's Lymphoma Trial (SHR-A1912; R-Chemo)

Not yet recruiting
  • B-cell Non-Hodgkin's Lymphoma
  • SHR-A1912; R-Chemo
  • (no location specified)
Oct 23, 2023

Squamous Cell Carcinoma of the Oral Cavity Trial in Rouen (Circulating tumor DNA detection)

Not yet recruiting
  • Squamous Cell Carcinoma of the Oral Cavity
  • Circulating tumor DNA detection
  • Rouen, France
  • +1 more
Jun 29, 2023

Role of PET/CT in Peritoneal Deposits Assessment

Not yet recruiting
  • Peritoneal Metastases
  • PET/CT
  • (no location specified)
Nov 14, 2023

Intra-operative Hyperspectral Imaging in Neurosurgery

Recruiting
  • Neurosurgery
  • +2 more
    • London, United Kingdom
      King's College NHS Foundation Trust
    Aug 16, 2022

    Locally Advanced Pancreatic Cancer Trial in Shanghai (Tumor treating fields combined with Gemcitabine HCl and albumin binding

    Not yet recruiting
    • Locally Advanced Pancreatic Cancer
    • Tumor treating fields combined with Gemcitabine hydrochloride and albumin binding paclitaxel
    • Gemcitabine hydrochloride and albumin binding paclitaxel
    • Shanghai, Shanghai, China
      Huashan Hospital Affiliated to Fudan University
    Dec 8, 2022

    Malignant Solid Tumors, Primary Brain Tumor, Melanoma Trial in Saint Petersburg

    Recruiting
    • Malignant Solid Tumors
    • +6 more
      • Saint Petersburg, Russian Federation
        N.N. Petrov NMRC of Oncology, Oncoimmunology dep.
      Sep 13, 2022